RAMM Pharma Corp. RAMM
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -635.60K | -202.00K | -547.00K | -5.16M | -380.70K |
| Total Depreciation and Amortization | 90.70K | 74.70K | 87.50K | 85.40K | 110.20K |
| Total Amortization of Deferred Charges | 400.00 | 400.00 | 500.00 | 400.00 | -- |
| Total Other Non-Cash Items | -822.40K | -118.20K | -278.60K | 3.72M | -5.20K |
| Change in Net Operating Assets | 1.44M | -444.60K | 495.20K | 1.29M | 101.50K |
| Cash from Operations | 74.30K | -689.60K | -242.50K | -60.40K | -174.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -40.90K | 66.80K | 395.80K | 269.80K | 36.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -40.90K | 66.80K | 395.80K | 269.80K | 36.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -17.00K | -17.00K | -18.70K | -17.10K | -17.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.30K | -- | -- | -400.00 | -8.20K |
| Cash from Financing | -13.80K | -12.40K | -13.50K | -12.70K | -18.30K |
| Foreign Exchange rate Adjustments | 100.00 | 3.60K | -8.90K | 1.10K | -1.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.80K | -631.60K | 130.90K | 197.80K | -157.20K |